About
Nucleic Acid Therapeutic Delivery
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
408
By Phase
PHASE1: 4
By Status
ACTIVE_NOT_RECRUITING: 3COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06633757Lead Sponsor
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
PHASE1Active, not recruiting
12 participants
Started: Oct 22, 2024 · Completed: Dec 30, 2025
NCT06600425Lead Sponsor
A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD
PHASE1Completed
7 participants
Started: Sep 20, 2024 · Completed: Aug 27, 2025
NCT06237335Lead Sponsor
A Phase 1 Study Evaluating Safety and Tolerability of RCT2100 (in CF mRNA) in Healthy Participants and in Participants With CF
PHASE1Recruiting
180 participants
Started: Feb 1, 2024 · Completed: Mar 30, 2026
NCT06172374Lead Sponsor
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
N/AActive, not recruiting
150 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
NCT05685186Lead Sponsor
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
N/AActive, not recruiting
50 participants
Started: Mar 8, 2023 · Completed: Jun 30, 2025
Locations (1)
Headquarters
Menlo Park, CA, United States
Map
Loading map...